Herb-partitioned Moxibustion Plus Lifestyle Modification Treatment for Simple Obesity
Comparative Effectiveness of Herb-partitioned Moxibustion Plus Lifestyle Modification Treatment for Patients With Simple Obesity: A Study Protocol for a Randomized Controlled Trial
1 other identifier
interventional
108
1 country
1
Brief Summary
This study is designed as a three-dummy randomised controlled trial to evaluate the efficacy and safety of herb-partitioned moxibustion plus lifestyle modification treatment in patients with simple obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedFirst Submitted
Initial submission to the registry
October 20, 2020
CompletedFirst Posted
Study publicly available on registry
October 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedOctober 28, 2020
October 1, 2020
1 year
October 20, 2020
October 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the clinical effectiveness
The clinical effectiveness of 4 weeks of (A)Heat application group, (B)Medicated plaster group, and (C)Herb-partitioned moxibustion group for the improvement of simple obesity will be assessed and determined by the clinical evaluation of nimodipine: 1. Healing: The clinical symptoms disappear or almost disappear, and the syndrome score is reduced by ≥85 percent; 2. Significant effect: The clinical symptoms are obviously improved, and the syndrome score is reduced by \<85 percent, but ≥50 percent; 3. Effective: The clinical symptoms have improved, syndrome scores decreased by\<50 percent, but ≥30 percent; 4. Invalid: The clinical symptoms were not improved, even worse, and the syndrome score was reduced by\<30 percent. Integral variation formula(Nimodipine method: \[(pre-treatment score-post-treatment score)/pre-treatment score\]X100 percent.
week 4.
Secondary Outcomes (10)
Weight(WG)
week 0, 1, 2, 3, and 4
BMI (weight/(height)
week 0, 1, 2, 3, and 4
Body fat percentage(F percent)
week 0, 1, 2, 3, and 4
Waist circumference(WC)
week 0, 1, 2, 3, and 4
hip circumference(HC)
week 0, 1, 2, 3, and 4
- +5 more secondary outcomes
Study Arms (3)
Heat application group
EXPERIMENTALParticipants will receive heat application at acupoints plus lifestyle modification. Participants will receive heat application treatment once every other day, 3 times per week, for 4 consecutive weeks.
Medicated plaster group
EXPERIMENTALParticipants will receive medicated plaster at acupoints plus lifestyle modification. Participants will receive medicated plaster at acupoints and lifestyle modification every once every other day, 3 times per week, for 4 consecutive weeks.
Herb-partitioned moxibustion group
EXPERIMENTALParticipants will receive herb-partitioned moxibustion at acupoints plus lifestyle modification. Participants will receive herb-partitioned moxibustion at acupoints and lifestyle modification every once every other day, 3 times per week, for 4 consecutive weeks.
Interventions
1. The acupoints will be selected as Tianshu, Pishu, shenshu, zhongwan, and zusanli. The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard. The hot sticker will be placed on the patient's acupoints for about 2 hours. This treatment will be applied once every other day, 3 times per week, for 4 consecutive weeks. The treatment will be delayed during the menstrual period. 2. The following lifestyle modification are recommended to help to establish healthy habits: The proportion of three nutrients in total calories comprises of 55%-65% from carbohydrates, 20%-30% from oils and 15% from protein, and the energy of the whole day distributed to three meals will follow the proportion of 30% for breakfast, 40% for lunch and 30% for dinner. Meanwhile, low-to-moderate intensity physical activities will be instructed to them for at least 5 days per week continually, 30%-50% of the maximum heart rate reserve value will be required.
1. The acupoints will be selected as Tianshu, Pishu, shenshu, zhongwan, and zusanli. The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.The chinese traditional medicine(aconite root, dried ginger, evodia rutaecarpa, clove, cinnamon, etc)in moderation will be grinded into powder,and the powder will be added with a certain amount of flour, and finally they will be blended with ginger juice to the appearance of mud. Next, 10g of the kneaded medicine mud will be taked and applied to the bottom of the ordinary sticker. They will be placed on the patient's acupoints for about 2 hours. The sticker has the same shape as the hot sticker, but it does not have the effect of thermal stimulation and infrared radiation. This treatment will be applied once every other day, 3 times per week, for 4 consecutive weeks. The treatment will be delayed during the menstrual period. 2. Lifestyle modification:It will be performed as the same as the heat application group.
1. The acupoints will be selected as Tianshu, Pishu, shenshu, zhongwan, and zusanli. The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard\[18\]. The chinese traditional medicine(aconite root, dried ginger, evodia rutaecarpa, clove, cinnamon, etc)in moderation will be grinded into powder,and the powder will be added with a certain amount of flour, and finally they will be blended with ginger juice to the appearance of mud. Next, 10g of the kneaded medicine mud will be taked and applied to the bottom of the hot sticker. They will be placed on the patient's acupoints for about 2 hours. This treatment will be applied once every other day, 3 times per week, for 4 consecutive weeks. The treatment will be delayed during the menstrual period. 2. Lifestyle modification:It will be performed as the same as the heat application group.
Eligibility Criteria
You may qualify if:
- diagnosed as having simple obesity according to the diagnostic criteria;
- aged between 18 and 45 years old;
- Waistline: male≥ 95 cm, women≥85 cm;
- Being able to fully understand and voluntarily sign informed consent.
You may not qualify if:
- Participants will be excluded if they have
- Presence of endocrine disorders such as: polycystic ovary syndrome; Cushing's syndrome; uncorrected thyroid disease.
- Presence of diabetes mellitus, or hypertension, or abnormal liver and kidney functions, or mental diseases.
- Pregnant or lactating state, women who plan to become pregnant within 4 weeks.
- History of bulimia, anorexia, or any other eating disorders.
- Use of medications in the past 3 months, such as diet drugs, corticosteroids, antidepressants, which may affect weight or appetite.
- History of surgical weight loss, postoperative adhesions.
- History of participating in a clinical study of weight loss or any other therapies to lose weight in the past 3 months.
- Presence of local skin rupture, allergy and scar constitution.
- Unable to cooperate with the research caused by other diseases or reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhong-Yu Zhou
Hubei, China
Related Publications (1)
Wang LH, Lv SY, Liu YR, Chen X, Wang JJ, Huang W, Zhou ZY. Comparative effectiveness of herb-partitioned moxibustion plus lifestyle modification treatment for patients with simple obesity: A study protocol for a randomized controlled trial. Medicine (Baltimore). 2021 Jan 22;100(3):e23758. doi: 10.1097/MD.0000000000023758.
PMID: 33545941DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhong-Yu Zhou, professor
Hubei Hospital of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2020
First Posted
October 28, 2020
Study Start
April 30, 2019
Primary Completion
April 30, 2020
Study Completion
April 30, 2021
Last Updated
October 28, 2020
Record last verified: 2020-10